Code | 1037F | ||||||||||
MA number | 29/0299/25-S | ||||||||||
Product Form: | sol por 1x60 ml/15 mg (fľ.skl.jantár.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | IASIS PHARMA , Greece | ||||||||||
Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | amber glass bottle | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(3) hybrid application |
MA issued: | 12.09.2025 |
Validity: | 12.09.2030 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
SPC: |
|
PIL: |
|
Safety feature | Yes |
Data update: | 16.09.2025 |